000 01577 a2200397 4500
005 20250515123624.0
264 0 _c20090130
008 200901s 0 0 eng d
022 _a1479-6813
024 7 _a10.1677/JME-08-0010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPietrzak, Maciej
245 0 0 _aTriiodothyronine utilizes phosphatidylinositol 3-kinase pathway to activate anti-apoptotic myeloid cell leukemia-1.
_h[electronic resource]
260 _bJournal of molecular endocrinology
_cSep 2008
300 _a177-86 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCell Line
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMyeloid Cell Leukemia Sequence 1 Protein
650 0 4 _aPhosphatidylinositol 3-Kinases
_xmetabolism
650 0 4 _aProtein Binding
_xdrug effects
650 0 4 _aProtein Isoforms
_xmetabolism
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xgenetics
650 0 4 _aReceptors, Thyroid Hormone
_xmetabolism
650 0 4 _aResponse Elements
650 0 4 _aRetinoid X Receptors
_xmetabolism
650 0 4 _aSequence Deletion
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTranscription, Genetic
_xdrug effects
650 0 4 _aTriiodothyronine
_xpharmacology
700 1 _aPuzianowska-Kuznicka, Monika
773 0 _tJournal of molecular endocrinology
_gvol. 41
_gno. 3
_gp. 177-86
856 4 0 _uhttps://doi.org/10.1677/JME-08-0010
_zAvailable from publisher's website
999 _c18037397
_d18037397